Agreement offers new HIV prevention possibilities for women
The International Partnership for Microbicides (IPM) announced that it has received exclusive worldwide rights to a promising HIV prevention medicine called dapivirine from Janssen R&D Ireland. The agreement expands on IPM’s existing rights to develop, manufacture and commercialize dapivirine-based products for...